LCM
MIRM icon

Laurion Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Laurion Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43,908
Closed -$967K – 617
2022
Q1 		$967K Buy
+43,908
New +$896K 0.01% 250
2021
Q1 		– Sell
-41,800
Closed -$730K – 834
2020
Q4 		$730K Buy
+41,800
New +$822K 0.01% 444

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Laurion Capital Management's MIRM Position: Q2 2022 in Review

Laurion Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2022, closing a stake of 43,908 shares — an estimated $967K sold.

Laurion Capital Management first reported a position in MIRM in Q4 2020 and held it in 2 quarters. The position peaked at $967K in Q1 2022. 109 funds tracked by Wall St. Rank hold MIRM as of Q2 2022.

  • Laurion Capital Management reported no remaining Mirum Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Laurion Capital Management sold 43,908 Mirum Pharmaceuticals shares in Q2 2022, an estimated $967K.
  • Laurion Capital Management first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Laurion Capital Management's Mirum Pharmaceuticals position peaked at $967K in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2022.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.